Cures vs. Profits

The potential of CAR T cell therapies raises important questions about the balance between curing diseases and the profit motives of drug companies. While some researchers believe these therapies could lead to cures for various conditions, including autoimmune diseases, the economic implications for the pharmaceutical industry remain a concern. Ultimately, the promise of cellular therapy could herald a new era in medicine, prompting society to adapt to these advancements.